Volume 15 Issue 2
Mar.  2024
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2024  >  15(2): 263-269
Dong Kun, Su Ruiling, Chen Junze, et al. Adenine phosphoribosyltransferase deficiency after kidney transplantation: a case report and literature review[J]. ORGAN TRANSPLANTATION, 2024, 15(2): 263-269. doi: 10.3969/j.issn.1674-7445.2023182
Citation: Dong Kun, Su Ruiling, Chen Junze, et al. Adenine phosphoribosyltransferase deficiency after kidney transplantation: a case report and literature review[J]. ORGAN TRANSPLANTATION, 2024, 15(2): 263-269. doi: 10.3969/j.issn.1674-7445.2023182
shu

Adenine phosphoribosyltransferase deficiency after kidney transplantation: a case report and literature review

doi: 10.3969/j.issn.1674-7445.2023182
  • 1.

    Department of Organ Transplantation, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China

More Information
  • Corresponding author: Dong Chunqiang, Email: dongchunqiang@163.com
  • Received Date: 2023-09-28
    Available Online: 2024-01-05
  • Publish Date: 2024-03-15
    Abstract
  •   Objective  To summarize the diagnosis and treatment experience of adenine phosphoribosyltransferase deficiency after kidney transplantation.   Methods  Clinical data of 1 patient with adenine phosphoribosyltransferase deficiency after kidney transplantation were retrospectively analyzed. Clinical characteristics, diagnosis, treatment and prognosis of adenine phosphoribosyltransferase deficiency were summarized by literature review.   Results  Renal biopsy showed that salt crystallization was found in most renal tubule lumen and positive results were observed under polarized light microscopy. After allopurinol, hemodialysis and anti-crystallization treatment, the graft function was gradually recovered. After postoperative 1-year follow-up, the patient's renal function was properly recovered.   Conclusions  Adenine phosphoribosyltransferase deficiency after kidney transplantation may lead to delayed graft function or graft dysfunction. Early detection, diagnosis and treatment may delay disease progression and improve renal function.

     

    • FullText(HTML)
  • loading
    • References(38)
  • [1]
    HUYET J, OZEIR M, BURGEVIN MC, et al. Structural insights into the forward and reverse enzymatic reactions in human adenine phosphoribosyltransferase[J]. Cell Chem Biol, 2018, 25(6): 666-676. DOI: 10.1016/j.chembiol.2018.02.011.
    [2]
    宋远明, 赵长永, 李道兵. 遗传性代谢缺陷所致肾结石研究进展[J]. 浙江大学学报(医学版), 2023, 52(2): 169-177. DOI: 10.3724/zdxbyxb-2022-0698.

    SONG YM, ZHAO CY, LI DB. Research progress on renal calculus associate with inborn error of metabolism[J]. J Zhejiang Univ (Med Sci), 2023, 52(2): 169-177. DOI: 10.3724/zdxbyxb-2022-0698.
    [3]
    刘宇坤, 葛玉成, 詹睿超, 等. 与嘌呤代谢相关的单基因肾结石病的研究进展[J]. 中华泌尿外科杂志, 2022, 43(2): 156-160. DOI: 10.3760/cma.j.cn112330-20211008-00531.

    LIU YK, GE YC, ZHAN RC, et al. Advances of monogenic kidney stone diseases associated with purine metabolism[J]. Chin J Urol, 2022, 43(2): 156-160. DOI: 10.3760/cma.j.cn112330-20211008-00531.
    [4]
    CEBALLOS-PICOT I, SAHA A, ARORA N, et al. Adenine phosphoribosyltransferase deficiency due to novel mutation[J]. Kidney Int Rep, 2018, 4(4): 624-628. DOI: 10.1016/j.ekir.2018.12.004.
    [5]
    HORINO T, ISHIHARA M, FUJIEDA M. Urinary 2, 8-dihydroxyadenine crystals in a patient with adenine phosphoribosyltransferase deficiency[J]. QJM, 2023, 116(10): 855-856. DOI: 10.1093/qjmed/hcad124.
    [6]
    NANMOKU K, KUROSAWA A, SHINZATO T, et al. Febuxostat for the prevention of recurrent 2, 8-dihydroxyadenine nephropathy due to adenine phosphoribosyltransferase deficiency following kidney transplantation[J]. Intern Med, 2017, 56(11): 1387-1391. DOI: 10.2169/internalmedicine.56.8142.
    [7]
    LI J, SHINGDE M, NANKIVELL BJ, et al. Adenine phosphoribosyltransferase deficiency: a potentially reversible cause of CKD[J]. Kidney Int Rep, 2019, 4(8): 1161-1170. DOI: 10.1016/j.ekir.2019.04.021.
    [8]
    RASHID I, VERMA A, TIWARI P, et al. Adenine phosphoribosyl transferase deficiency leads to renal allograft dysfunction in kidney transplant recipients: a systematic review[J]. J Bras Nefrol, 2022, 44(3): 403-416. DOI: 10.1590/2175-8239-JBN-2021-0283en.
    [9]
    KAARTINEN K, HEMMILÄ U, SALMELA K, et al. Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction[J]. J Am Soc Nephrol, 2014, 25(4): 671-674. DOI: 10.1681/ASN.2013090960.
    [10]
    BRILLAND B, AUGUSTO JF, CROUE A, et al. A rare case of primary non-function of renal allograft due to adenine phosphoribosyltransferase deficiency[J]. Int Urol Nephrol, 2015, 47(9): 1589-1591. DOI: 10.1007/s11255-015-1077-y.
    [11]
    GEORGE SA, AL-RUSHAIDAN S, FRANCIS I, et al. 2, 8-Dihydroxyadenine nephropathy identified as cause of end-stage renal disease after renal transplant[J]. Exp Clin Transplant, 2017, 15(5): 574-577. DOI: 10.6002/ect.2015.0096.
    [12]
    BAGAI S, KHULLAR D, BANSAL B. Rare crystalline nephropathy leading to acute graft dysfunction: a case report[J]. BMC Nephrol, 2019, 20(1): 428. DOI: 10.1186/s12882-019-1616-3.
    [13]
    RAJPUT P, VIRANI ZA, SHAH BV. Crystalline nephropathy due to aprt deficiency: a preventable cause of renal and renal allograft failure[J]. Indian J Nephrol, 2020, 30(4): 290-292. DOI: 10.4103/ijn.IJN_106_19.
    [14]
    BALASUBRAMANIAM GS, ARENAS-HERNANDEZ M, ESCUREDO E, et al. Adenine phosphoribosyltransferase deficiency in the United Kingdom: two novel mutations and a cross-sectional survey[H]. Clin Kidney J, 2016, 9(6): 800-806. DOI: 10.1093/ckj/sfw093.
    [15]
    CHENG Y, GUO L, WANG M, et al. Recurrence of 2, 8-dihydroxyadenine crystalline nephropathy in a kidney transplant recipient: a case report and literature review[J]. Intern Med, 2021, 60(16): 2651-2657. DOI: 10.2169/internalmedicine.6640-20.
    [16]
    KUNOU M, YAMAGUCHI M, TAKAHASHI H, et al. A case of 2, 8-DHA crystalline nephropathy caused by adenine phosphoribosyltransferase deficiency: diagnosis and treatment[J]. CEN Case Rep, 2023, 12(3): 329-334. DOI: 10.1007/s13730-022-00768-1.
    [17]
    YAMAZAKI K, MIYAZAWA K, NIDA Y, et al. Rapidly progressive kidney dysfunction and crystal casts associated with adenine phosphoribosyltransferase (APRT) deficiency-lessons for the clinical nephrologist[J]. J Nephrol, 2021, 34(6): 2147-2149. DOI: 10.1007/s40620-021-01042-w.
    [18]
    SHIMOYAMA K, KANZAKI G, OKUBO A, et al. Foreign body granuloma with crystals, recurrent kidney stones, in a patient with adenine phosphoribosyltransferase deficiency[J]. QJM, 2023, 116(7): 536-537. DOI: 10.1093/qjmed/hcad037.
    [19]
    CHONG SL, NG YH. Obstructive uropathy and severe acute kidney injury from renal calculi due to adenine phosphoribosyltransferase deficiency[J]. World J Pediatr, 2016, 12(2): 243-245. DOI: 10.1007/s12519-015-0073-8.
    [20]
    NAJAFIAN B, LUSCO MA, ALPERS CE, et al. Approach to kidney biopsy: core curriculum 2022[J]. Am J Kidney Dis, 2022, 80(1): 119-131. DOI: 10.1053/j.ajkd.2021.08.024.
    [21]
    CHOY B, NAYAR R, LIN X. Role of renal mass biopsy for diagnosis and management: review of current trends and future directions[J]. Cancer Cytopathol, 2023, 131(8): 480-494. DOI: 10.1002/cncy.22697.
    [22]
    米爱红, 高瑞瑞, 戴毅, 等. 超声引导下经皮肾穿刺活检在慢性肾脏病诊断中的价值[J]. 中国实验诊断学, 2023, 27(7): 808-810. DOI: 10.3969/j.issn.1007-4287.2023.07.014.

    MI AH, GAO RR, DAI Y, et al. The value of ultrasound-guided percutaneous renal biopsy in the diagnosis of chronic kidney disease[J]. Chin J Lab Diagn, 2023, 27(7): 808-810. DOI: 10.3969/j.issn.1007-4287.2023.07.014.
    [23]
    SINKS A, MILLER C, HOLCK H, et al. Renal mass biopsy mandate is associated with change in treatment decisions[J]. J Urol, 2023, 210(1): 72-78. DOI: 10.1097/JU.0000000000003429.
    [24]
    CHUNG R, KURTZMAN JT, GILLESPIE A, et al. The utility of renal mass biopsy in shared decision-making for renal mass treatment[J]. Urology, 2023, 178: 98-104. DOI: 10.1016/j.urology.2023.04.023.
    [25]
    BERTRAM A, BROECKER V, LEHNER F, et al. Kidney transplantation in a patient with severe adenine phosphoribosyl transferase deficiency: obstacles and pitfalls[J]. Transpl Int, 2010, 23(9): e56-e58. DOI: 10.1111/j.1432-2277.2010.01128.x.
    [26]
    DOLEŽELOVÁ E, KLEJCH T, ŠPAČEK P, et al. Acyclic nucleoside phosphonates with adenine nucleobase inhibit Trypanosoma brucei adenine phosphoribosyltransferase in vitro[J]. Sci Rep, 2021, 11(1): 13317. DOI: 10.1038/s41598-021-91747-6.
    [27]
    VALAPERTA R, RIZZO V, LOMBARDI F, et al. Adenine phosphoribosyltransferase (APRT) deficiency: identification of a novel nonsense mutation[J]. BMC Nephrol, 2014, 15: 102. DOI: 10.1186/1471-2369-15-102.
    [28]
    RUNOLFSDOTTIR HL, PALSSON R, AGUSTSDOTTIR IM, et al. Kidney disease in adenine phosphoribosyltransferase deficiency[J]. Am J Kidney Dis, 2016, 67(3): 431-438. DOI: 10.1053/j.ajkd.2015.10.023.
    [29]
    SINGH A, RAMACHANDRAN R, CHANDRALEKHA C, et al. Timing of intraoperative crystalloid infusion may decrease total volume of infusate without affecting early graft function in live related renal transplant surgery: a randomized, surgeon-blinded clinical study[J]. Indian J Urol, 2022, 38(1): 53-61. DOI: 10.4103/iju.iju_239_21.
    [30]
    DONG Y, SILVER SM, STERNS RH. Estimating urine volume from the urine creatinine concentration[J]. Nephrol Dial Transplant, 2023, 38(4): 811-818. DOI: 10.1093/ndt/gfab337.
    [31]
    OHYAMA T, SAKA N, TSUJIMOTO Y. Is allopurinol administration really effective in renal transplant patients?[J]. Transpl Immunol, 2022, 75: 101700. DOI: 10.1016/j.trim.2022.101700.
    [32]
    BOLLÉE G, DOLLINGER C, BOUTAUD L, et al. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency[J]. J Am Soc Nephrol, 2010, 21(4): 679-688. DOI: 10.1681/ASN.2009080808.
    [33]
    BOLLÉE G, HARAMBAT J, BENSMAN A, et al. Adenine phosphoribosyltransferase deficiency[J]. Clin J Am Soc Nephrol, 2012, 7(9): 1521-1527. DOI: 10.2215/CJN.02320312.
    [34]
    YASEEN W, AUGUSTE B, ZIPURSKY J. Allopurinol hypersensitivity syndrome[J]. CMAJ, 2023, 195(13): E483. DOI: 10.1503/cmaj.221575.
    [35]
    MOHAMMAD CM, SHAHIDAH CA, WAN FATIMAH SWM, et al. Delayed hypersensitivity reaction to allopurinol: a case report[J]. Malays Fam Physician, 2023, 18: 11. DOI: 10.51866/cr.65.
    [36]
    HUONG PT, HA TN, NHU TTQ, et al. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: signal detection and preventability from Vietnam National pharmacovigilance database[J]. J Clin Pharm Ther, 2022, 47(12): 2014-2019. DOI: 10.1111/jcpt.13740.
    [37]
    BATHINI L, GARG AX, SONTROP JM, et al. Initiation dose of allopurinol and the risk of severe cutaneous reactions in older adults with CKD: a population-based cohort study[J]. Am J Kidney Dis, 2022, 80(6): 730-739. DOI: 10.1053/j.ajkd.2022.04.006.
    [38]
    EDVARDSSON VO, RUNOLFSDOTTIR HL, THORSTEINSDOTTIR UA, et al. Comparison of the effect of allopurinol and febuxostat on urinary 2, 8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency (APRTd): a clinical trial[J]. Eur J Intern Med, 2018, 48: 75-79. DOI: 10.1016/j.ejim.2017.10.007.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (169) PDF downloads(29) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return